Buy Ceat Limited and Sanofi India Limited

Buy Ceat Limited:

Ceat Limited

Ceat Ltd has officially announced a consolidated sales of Rs. 2,225.30 Cr for the third quarter finished on 31-12-2020, which is 12.26% down from its previous quarter sales of Rs. 1,982.24 Cr and 26.06% up from its previous year same quarter sales of Rs. 1,765.34 Cr. The company has reported a net profit after tax of Rs. 120.64 Cr in the previous quarter.

Outlook:

Ceat Ltd: Experts suggested buy call at current market price: Rs. 1,637 with a target price: Rs. 1,750.

Buy Sanofi India Limited:

Sanofi India Limited

Sanofi India Ltd has officially announced a consolidated sales of Rs. 736.50 Cr for the third quarter finished on 31-12-2020, which is 4.99% up from its previous quarter sales of Rs. 701.50 Cr and -13.46% down from its previous year same quarter sales of Rs. 851.10 Cr. The company has reported a net profit after tax of Rs. 123.00 Cr in the previous quarter.

Outlook:

Sanofi India Ltd: Experts suggested buy call at current market price: Rs. 8,165.4 with a target price: Rs. 9,820.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.